Conclusion: CD4 cell count can reflect the degree of immunosuppression in PTB patient irrespective of their HIV status but it cannot predict the disease severity in PTB patient.
INTRODUCTION
related to the CD8 cells in the peripheral blood and bronchoalveolar lavage fluid. 3 This proposed study aims at evaluating and understand the change of CD4 T lymphocyte cell count in PTB patient with and without HIV presenting at one of the tertiary care hospital of eastern Nepal.
METHODS
This was a hospital based comparative crosssectional study conducted from May 2012 to April 2013 in one of the tertiary care hospital of eastern Nepal.
The study population consisted of four groups of newly diagnosed PTB patient without HIV; HIV/TB co-infected patient; newly diagnosed HIV patient without TB and Healthy adults for reference values.
The total HIV/TB co-infected patients diagnosed in the hospital over the period of one year were taken into account and equal number to each group was allocated accordingly. Total 40 HIV/TB co-infected patients were diagnosed over the study period; hence, the total number of individuals in the study was 160, each group with 40 individuals.
All the sputum negative or extra-pulmonary TB along with defaulter, relapse or re-infected cases were excluded from this study. Patient with immune compromised state other than HIV or who were already under treatment for TB or HIV were also excluded.
Smear positive PTB was diagnosed according to National Guidelines being at least two out of three sputum samples showing acid-fast bacilli by Ziehl Neelsen (ZN) staining. 4 All newly diagnosed PTB patients during the study period were counseled about the study and HIV counseling and testing was done for those who gave written consent. Those who consented
were asked for blood sample in ethylene diamine-tetra-acetic acid (EDTA) tubes. The same sample was used for HIV test and for CD4 T cell counts.
Newly diagnosed HIV patient attending the VCT clinic and CD4 Laboratory were counseled about the study. Those who consented were asked to give sputum samples, which were sent to the TB laboratory for smear microscopy. Sputum sample was obtained from each patient according to NTP guideline. 4 Tuberculosis diagnosis was made based on the finding of AFB by fluorescence microscopy followed by Ziehl Neelsen (ZN) staining.
Blood was collected in ethylene (EDTA) tubes for CD4 T cell counts. 
RESULTS
A total of 160 individuals were enrolled during the study period. to the HIV/TB population in this study. 32, 33 This disparity could be due to the result of higher absolute CD4 level in their healthy population. However, the overall decrease in all the above mentioned studies showed statistically significant result.
DISCUSSION
This study showed that there is significant decrease in the CD4 cell level in PTB patient than the healthy population, which further decreases severely with HIV co-infection. Evaluation of CD4 cells were done prior to initiation of ATT in primary PTB patients but follow-up after ATT, sputum sample being negative or at the end of completion of therapy could not be done due to limited study period.
Hence the level of CD4 cells at the end of therapy needs to be determined and it remains as a field of further study in the future.
